SafiF., SchlosserW., FalkenreckS.Prognostic value of CA 19–9 serum course in pancreatic cancer.Hepatogastroenterology1998; 45: 253–9.
2.
LamerzR.Role of tumour markers, cytogenetics.Ann Oncol1999; 4: 145–9.
3.
Sheen-ChenS.M., SunC.K., LiuY.W.Extremely elevated CA 19–9 in acute cholangitis.Dig Dis Sci2008; 53: 1432.
4.
AkG., OzelA.M.Elevated CA 19–9 levels in patient with choledocholithiasis.Turk J Gastroenterol2002; 13: 213–5.
5.
Uygur-BayramicliO., DabakR., OrbayE.Type 2 diabetes mellitus and CA 19–9 levels.World J Gastroenterol2007; 13: 5357–9.
6.
OngS.L., SachdevaA., GarceaG.Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration.Dig Dis Sci2008; 53: 3213–7.